Bluesight has introduced Prism, a new Hospital AI Platform designed for hospital pharmacy and compliance operations, with the company launching Prism Assistant as the first application within the system. The assistant is now integrated into ControlCheck, Bluesight’s drug diversion monitoring software, where it enables diversion teams to analyze controlled substance information and behavioral patterns through natural language queries. According to the company, the tool reduces investigative analysis tasks from days to seconds and can cut time spent on controlled substance variance analysis by up to 97%.
The launch follows increasing use of artificial intelligence tools within hospital pharmacy environments. Bluesight’s 2026 research found that 24% of pharmacy leaders currently use AI every day, while 35% of diversion professionals already depend on tools such as ChatGPT and Microsoft Copilot to review controlled substance data. Prism Assistant was developed specifically for diversion monitoring workflows rather than general-purpose AI applications. The company stated that the platform functions entirely within its secure infrastructure, uses integrated ControlCheck data sources, and aligns with Google’s Secure AI Framework (SAIF). “Demand for generative AI in diversion monitoring is already here,” said Kevin MacDonald, CEO and co-founder of Bluesight. “But many teams are using tools that weren’t built for sensitive healthcare data or diversion workflows. Prism Assistant delivers the speed they need while keeping data secure and grounded in the workflows they already trust.”
Using Prism Assistant, diversion teams can request reports, graphs, and evidence-backed responses related to provider behavior and controlled substance trends in less than a minute. Bluesight said this allows staff to spend more time on higher-priority investigations, regulatory compliance activities, and diversion confirmation processes instead of manually assembling data. Twenty health systems are already deploying the assistant within ControlCheck for peer comparisons, executive reporting, and staff investigation analysis. Reported outcomes include recurring reports being completed 96% faster, pre-investigation triage reduced from three hours to around 10 minutes, and detailed variance analysis shortened from 30 minutes to under a minute. Bluesight also confirmed the Hospital AI Platform will expand into PrivacyPro later this year while the company develops agentic AI capabilities capable of handling multi-step workflows independently.
